Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

medius ag - toxinum botulinicum a (stirpis cbfc26) - polvere per soluzione iniettabile - praeparatio cryodesiccata: toxinum botulinicum a (stirpis cbfc26) 50 u., albuminum humanum, natrii chloridum corresp. natrium 0.18 mg, pro vitro. - zur vorübergehenden verbesserung des erscheinungsbildes mittelstarker bis starker vertikaler falten zwischen den augenbrauen bei erwachsenen <75 jahren, die bei maximalem stirnrunzeln auftreten (glabellafalten), wenn das ausmass der gesichtsfalten eine erhebliche psychologische belastung darstellt. - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pharmacons gmbh - toxinum botulinicum a (stirpis kcdc) - polvere per soluzione iniettabile - praeparatio cryodesiccata: toxinum botulinicum a (stirpis kcdc) 50 u., albuminum humanum, natrii chloridum corresp. natrium 0.18 mg, pro vitro. - bei erwachsenen im alter unter 65 jahren zur vorübergehenden verbesserung des aussehens von mittelstarken bis starken vertikalen falten zwischen den augenbrauen, sichtbar bei maximalem stirnrunzeln (glabellafalten), wenn das ausmass dieser falten eine erhebliche psychologische belastung darstellt. - biotechnologika

Italia - italiano - Ministero della Salute

siapa s.r.l. - triclopyr; - concentrato solubile - 44.4 g i valori indicati sono per 100 g di prodotto. - diserbante - diserbante - (xn) nocivo

Italia - italiano - Ministero della Salute

arysta lifescience benelux sprl - triclopir butossietilen estere; - concentrato emulsionabile - 44.95 g i valori indicati sono per 100 g di prodotto. - diserbante - diserbante - (xn) nocivo

Italia - italiano - Ministero della Salute

weinmann gerÄte fÜr medizin gmbh+co.kg - apparecchiature per pressione positiva continua

Italia - italiano - Ministero della Salute

arysta lifescience benelux sprl - triclopir butossietilen estere; - concentrato emulsionabile - 10.55 g i valori indicati sono per 100 g di prodotto. - diserbante

Italia - italiano - Ministero della Salute

sharda europe b.v.b.a. - diquat (dibromide); - concentrato solubile - 17.0 g i valori indicati sono per 100 g di prodotto. - diserbante

Italia - italiano - myHealthbox

lemuria - antiossidante, remineralizzante, stanchezza

Italia - italiano - Ministero della Salute

erba vita spa -